Replies to post #7155 on BioPharm Asia, Inc (fka BFAR)

[loupai]

exactly. i thought it would be more like .50c, however..

but more importantly, news that FINRA refuted BFAR's PR, means 4c for the next few years b/f the SEC forces delisting.